These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 974553)

  • 21. Raynaud's phenomenon and systemic diseases.
    Kallenberg CG
    Vasa Suppl; 1987; 18():15-20. PubMed ID: 3299813
    [No Abstract]   [Full Text] [Related]  

  • 22. [Whole-blood and plasma viscosity in two cases of mixed connective tissue disease with Raynaud's phenomenon and cold agglutinemia].
    Nakazato K; Sakurai T; Kubota K; Kurabayashi H; Tamura J; Shirakura T
    Rinsho Byori; 1988 Oct; 36(10):1201-4. PubMed ID: 3246733
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemorrheological response to plasma exchange in Raynaud's syndrome.
    Dodds AJ; O'Reilly MJ; Yates CJ; Cotton LT; Flute PT; Dormandy JA
    Br Med J; 1979 Nov; 2(6199):1186-87. PubMed ID: 519354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter: Raynaud's disease and the oral contraceptive pill.
    Eastcott HH
    Br Med J; 1976 Aug; 2(6033):477. PubMed ID: 953634
    [No Abstract]   [Full Text] [Related]  

  • 25. Assessment of platelet function in patients with Raynaud's syndrome.
    Hutton RA; Mikhailidis DP; Bernstein RM; Jeremy JY; Hughes GR; Dandona P
    J Clin Pathol; 1984 Feb; 37(2):182-7. PubMed ID: 6229551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Rheologic properties of the blood in Raynaud's syndrome and disease].
    Kovalenko VI; Baturin LI
    Vestn Khir Im I I Grek; 1983 Aug; 131(8):37-9. PubMed ID: 6649277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered microrheological parameters in Raynaud's phenomenon.
    Papp J; Sandor B; Toth A; Biro K; Rabai M; Botor D; Kovacs D; Csernus Z; Toth K; Kesmarky G
    Clin Hemorheol Microcirc; 2017; 65(1):23-29. PubMed ID: 27258205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nomenclature of Raynaud's phenomenon: a capillary microscopic and hemorheologic study.
    Jacobs MJ; Breslau PJ; Slaaf DW; Reneman RS; Lemmens JA
    Surgery; 1987 Feb; 101(2):136-45. PubMed ID: 3810484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma-proteins and oral contraceptives.
    Lancet; 1970 Jan; 1(7637):72-3. PubMed ID: 4188630
    [No Abstract]   [Full Text] [Related]  

  • 30. Troxerutin in Raynaud's syndrome.
    Lund F; Cronestrand R; Sonnenfeld T
    Br Med J; 1980 Feb; 280(6210):334-5. PubMed ID: 7357370
    [No Abstract]   [Full Text] [Related]  

  • 31. Hemorheological profile in primary and secondary Raynaud's phenomenon. Influence of microangiopathy.
    Vayá A; Alis R; Romagnoli M; Todolí J; Calvo J; Ricart JM
    Clin Hemorheol Microcirc; 2014; 56(3):259-64. PubMed ID: 23609604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fish oil, Raynaud's syndrome, and undiscovered public knowledge.
    Swanson DR
    Perspect Biol Med; 1986; 30(1):7-18. PubMed ID: 3797213
    [No Abstract]   [Full Text] [Related]  

  • 33. [Finger plethysmography for studying the blood rheological and hemodynamic components of an acrosyndrome].
    de Faucal P; Planchon B; Boudard D; Peltier P; Barrier J; Grolleau JY
    J Mal Vasc; 1986; 11(4):356-61. PubMed ID: 3805897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The associations between plasma levels of von Willebrand factor and fibrinogen with Raynaud's phenomenon in men and women.
    Fraenkel L; Tofler GH; Zhang Y; Silbershatz H; D'Agostino RB; Wilson PW; Felson DT
    Am J Med; 2000 May; 108(7):583-6. PubMed ID: 10806290
    [No Abstract]   [Full Text] [Related]  

  • 35. Association of von Willebrand factor and fibrinogen plasma levels with primary Raynaud's phenomenon in male and female patients.
    Takáts AT; Shemirani AH; Zsóri KS; András C; Csiki Z
    Rheumatol Int; 2013 Apr; 33(4):1083-4. PubMed ID: 22108676
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical significance of Cryofibrinogenemia: possible pathophysiological link with Raynaud's phenomenon.
    Soyfoo MS; Goubella A; Cogan E; Wautrecht JC; Ocmant A; Stordeur P
    J Rheumatol; 2012 Jan; 39(1):119-24. PubMed ID: 22089468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral contraceptives and increased formation of soluble fibrin.
    Pilgeram LO; Ellison J; Von dem Bussche G
    Br Med J; 1974 Aug; 3(5930):556-8. PubMed ID: 4414937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autohaemagglutination and Raynaud's phenomenon.
    FORBES GB
    Br Med J; 1947 May; 1(4504):598-600. PubMed ID: 20248066
    [No Abstract]   [Full Text] [Related]  

  • 39. [Characteristic rheograms of pathological bloods. Application to dynamic pharmacology (author's transl)].
    Dufaux J; Quemada D; Mills P; Lambert M
    J Mal Vasc; 1980; 5(2):135-7. PubMed ID: 6780647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An experimentally controlled evaluation of the effect of inositol nicotinate upon the digital blood flow in patients with Raynaud's phenomenon.
    Holti G
    J Int Med Res; 1979; 7(6):473-83. PubMed ID: 391622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.